Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 857 일 전
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 601 일 전
Overbought Taiwan Bourse Nonetheless Called Higher On Monday

Overbought Taiwan Bourse Nonetheless Called Higher On Monday

The Taiwan stock market has finished higher in five straight trading days, rallying more than 1,300 points or 6.4 percent in that span. The Taiwan Stock Exchange now sits just above the 20,780-point plateau and it's got another solid lead for Monday's trade.
RTTNews | 5 분 전
Additional Upside Seen For Singapore Stock Market

Additional Upside Seen For Singapore Stock Market

The Singapore stock market has moved higher in back-to-back sessions, advancing almost 40 points or 1.1 percent along the way. The Straits Times Index now sits just above the 3,845-point plateau and it's likely to open to the upside again on Monday.
RTTNews | 35 분 전
Malaysia Stock Market May Extend Winning Streak

Malaysia Stock Market May Extend Winning Streak

The Malaysia stock market has moved higher in two straight sessions, collecting more than 25 points or 1.6 percent along the way. The Kuala Lumpur Composite Index now sits just above the 1,540-point plateau and it may add to its winnings again on Monday.
RTTNews | 1 시간 5 분 전
Indonesia GDP Data Due On Monday

Indonesia GDP Data Due On Monday

Indonesia will on Monday release Q1 figures for gross domestic product, highlighting a light day for Asia-Pacific economic activity.
RTTNews | 2 시간 5 분 전